Use of Levosimendan in Cardiac Anesthesiology
The authors consider the main aspects of the rational use of the novel inotropic drug levosimendan in cardiosurgical patients on the basis of the results of the trials described in the literature and on their own findings in this review. The purpose of the analysis made was to provide a rationale fo...
Príomhchruthaitheoirí: | L. A. Krichevsky, V. Yu. Rybakov, O. G. Guseva, I. E. Kharlamova, A. Yu. Lyamin |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
2011-08-01
|
Sraith: | Общая реаниматология |
Rochtain ar líne: | https://www.reanimatology.com/rmt/article/view/282 |
Míreanna comhchosúla
Míreanna comhchosúla
-
Pathophysiology of the Heart and Clinical Cardiac Anesthesiology
de réir: Yu. V. Nikiforov, et al.
Foilsithe / Cruthaithe: (2012-08-01) -
Early Diagnosis of Critical Postperfusion Circulatory Disorders
de réir: L. A. Krichevsky, et al.
Foilsithe / Cruthaithe: (2012-06-01) -
EVALUATION OF LEVOSIMENDAN EFFICIENCY IN CARDIAC SURGERY
de réir: I. A. Kozlov, et al.
Foilsithe / Cruthaithe: (2018-01-01) -
The Informative Value of N-Terminal Pro-type B Natriuretic Peptide in Cardiac Surgical Patients with Hypercreatininemia
de réir: M. G. Burzhunova, et al.
Foilsithe / Cruthaithe: (2011-12-01) -
CARDIAC PROTECTIVE INOTROPIC THERAPY – OPPORTUNITIES AND PROSPECTIVE OF USING LEVOSIMENDAN IN CARDIAC SURGERY
de réir: V. V. Pasyuga, et al.
Foilsithe / Cruthaithe: (2018-01-01)